Prostate cancer Board decisions

The Board has decided to remand the cases for further development regarding in-country Vietnam service and its impact on the Veteran's claims of prostate cancer and diabetes mellitus, type II.

The Board denied service connection for STD, prostate cancer, motion sickness/dizziness, and sleep apnea (secondary to PTSD). The TDIU claim is also remanded.

The Veteran's claims for increased ratings and TDIU are being remanded due to the need for additional development, including obtaining medical records from SSA.

The Board has remanded the claims of service connection for prostate cancer and headache disorder, to include as secondary to tinnitus. The Veteran's assertions regarding exposure to herbicides are not supported by his service records.

The Veteran's claims for service connection for residuals of prostate cancer and erectile dysfunction have been denied. The cervical spine, lumbar spine, bilateral shoulder arthritis, right hip arthritis, right knee arthritis, and bilateral ankle arthritis claims are remanded for further development.

The Board has remanded the Veteran's claim for a TDIU due to his service-connected prostate cancer. The case was previously before the Board multiple times, and in January 2015, it was remanded for additional development including a VA examination of the Veteran's residuals of prostate cancer. However, the August 2015 examiner did not review the claims file as requested. Therefore, a new examination is needed to determine the current severity of the Veteran’s residuals of prostate cancer.

The Veteran's prostate cancer was not incurred or aggravated by service, and the Board denied his claim for service connection. The appeal is also remanded for further examination regarding special monthly compensation based on need for aid and attendance/housebound.

The Veteran's combined disability rating for compensation is 80 percent effective October 1, 2015. The Board finds that the criteria for entitlement to a higher combined disability rating have not been met.

The Veteran's claim for service connection of Major Depressive Disorder was granted, but the appeal regarding his prostate cancer evaluation is being remanded.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no in-service event or disease and that exposure to Agent Orange during service on Johnston Island is not conceded. The Board also found that the evidence does not support a finding of any other relationship between the Veteran's prostate cancer and his military service.

The Board has remanded the case for additional development regarding the appellant's contention that the Veteran was exposed to chemicals other than tactical herbicides during service, which may be related to the claimed conditions.

The Veteran's appeal has been dismissed due to his death. The Board cannot proceed with the merits of the claims as they are now moot.

The Veteran's cause of death was not related to any injury or disease incurred during his service, including exposure to asbestos or radiation.

The Board has remanded the Veteran's claims for prostate cancer, diabetes mellitus type II, peripheral neuropathy of the left upper extremity, and peripheral neuropathy of the feet due to incomplete information regarding his exposure to herbicide agents during service.

The Board has remanded the case due to insufficient evidence regarding the appellant's exposure to herbicide agents, particularly Agent Orange. The appellant served in Thailand and Vietnam but claims he was exposed during TDY at Takhli Royal Thai Air Base in 1961.

The Veteran withdrew his appeals for both bilateral hearing loss and prostate cancer, so the cases are dismissed.

The Board has remanded the Veteran's claims for prostate cancer and bowel impairment, as well as his TDIU claim due to lack of recent VA examinations and outstanding private treatment records.

The Veteran's prostate cancer is not related to his military service, including any exposure to herbicides in Thailand. The claim for service connection is denied.

The Veteran's prostate cancer residuals were denied increased disability ratings in excess of the current assigned ratings for different time periods.

The Board has granted a 40 percent disability rating for the Veteran's residuals of prostate cancer, effective June 1, 2017. The decision also addressed the reduction in his prostate cancer rating from 100% to 20%, which was found proper.